As production of molybdenum-99 returns to normal with the Canadian Chalk River Laboratories reactor back online and the supply of 99m-technetium stabilizes, the nuclear cardiology community is anxiously waiting to see if procedure volumes will rebound.
If you enjoy this content, please share it with a colleague
- Read more about Time for a New Normal in Nuclear Cardiology?
- Log in or register to post comments
